BRCA1 and cancer: Interestingly, epigenetic defects in BRCA1 have been associated with increased sensitivity to platinum-derived drugs in human cancer [8–10], whilst an impairment of at least one BRCA1-interactor protein (SRBC) has been related to increased resistance to these compounds [13].